Beyond Next Ventures

Beyond Next Ventures, founded in 2014 and based in Tokyo, Japan, is a venture capital firm dedicated to fostering innovation in Japanese science and technology. The firm focuses on supporting motivated entrepreneurs who possess groundbreaking ideas, with the goal of commercializing these innovations to contribute to a better future and society. Beyond Next Ventures invests in a diverse range of sectors, including medtech, healthcare, drug discovery, biotechnology, agriculture, food, digital technology, space, and climate technology, with an emphasis on opportunities in Japan and India.

Akito Arima

Partner

Katsuya Hashizume

Executive Officer and Partner

Tsuyoshi Ito

CEO and Managing Partner

Yuichiro Sano

Manager and Venture Capitalist

Takehiko Sawabe

Principal

Kengo Ueha

Managing Director

Past deals in Japan

Secai Marche

Series A in 2024
Secai Marche Inc. operates an online marketplace that connects small-scale farmers with restaurants and consumers, facilitating direct purchases of high-quality food products. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the platform enhances the economic viability of small farms by improving their access to markets. Secai Marche offers services that include sourcing, order processing, payment, and delivery, allowing farmers to sell seasonal and regionally sourced ingredients directly to chefs and businesses. The company's mission is to promote sustainable farming practices and ensure that farmers can achieve a profitable livelihood while providing consumers with fresh and delicious food options.

Sakana Dream

Seed Round in 2023
Sakana Dream is a Japanese company specializing in aquaculture innovation. It employs a unique breeding technology called Surrogate Broodstock Technology to select and breed exceptional fish from over 4,000 species found in Japan. The company's focus is on creating hybrid fish that combine excellent taste with high productivity, aiming to contribute to sustainable and eco-friendly fish production.

Olive Union

Venture Round in 2023
Olive Union Inc. is a company that develops innovative hearing aids designed to enhance the hearing experience while addressing common issues related to cost and social stigma. Founded in 2016 and headquartered in Seoul, South Korea, the company utilizes advanced sound algorithms and smart technology to create hearing devices that integrate seamlessly with everyday products. Their devices feature a hearing process engine that allows users to make and receive calls and listen to music, while also offering a smartphone application for personalized hearing tests. This application automatically adjusts audio frequencies based on test results, providing users with optimized sound quality, noise cancellation, and improved hearing range. Olive Union aims to make hearing aids more accessible and socially acceptable, thus contributing to the elimination of hearing impairment.

BiPSEE

Venture Round in 2023
BiPSEE is a medical XR company based in Tokyo, Japan, specializing in the development of virtual and augmented reality solutions aimed at alleviating anxiety and pain in children during medical procedures. By integrating innovative technologies like AR and VR, BiPSEE offers treatment support that enhances children's self-efficacy in various healthcare settings, including dentistry, pediatrics, and dermatology. The company employs one-button dentistry and medicine techniques to create calming environments that can be used both in outpatient and hospitalized situations. Additionally, BiPSEE incorporates advanced cognitive-behavioral therapy methods to provide therapeutic experiences designed to help users change their perspectives and improve their mental well-being.

Secai Marche

Series A in 2023
Secai Marche Inc. operates an online marketplace that connects small-scale farmers with restaurants and consumers, facilitating direct purchases of high-quality food products. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the platform enhances the economic viability of small farms by improving their access to markets. Secai Marche offers services that include sourcing, order processing, payment, and delivery, allowing farmers to sell seasonal and regionally sourced ingredients directly to chefs and businesses. The company's mission is to promote sustainable farming practices and ensure that farmers can achieve a profitable livelihood while providing consumers with fresh and delicious food options.

The Ethical Spirits

Venture Round in 2022
The Ethical Spirits is a craft gin brand that focuses on sustainability by utilizing sake lees from Kuramae, Tokyo, and leftover beer, particularly in response to the challenges posed by the pandemic. The company aims to create a circular economy in the alcoholic beverage industry by producing not only gin but also whiskey and other related products. By offering a monthly subscription service, Ethical Spirits allows consumers to enjoy a variety of flavored drinks while promoting ethical practices in production. The brand aspires to establish itself as a long-lasting presence in the spirits market, aligning quality with environmental responsibility.

Grand Green

Series B in 2022
Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

IntegriCulture

Series A in 2022
IntegriCulture Inc., founded in 2015 and based in Bunkyo, Japan, specializes in the development of cellular agriculture products, including clean meat and clean foie gras. The company focuses on improving sustainability and food security while addressing public health issues associated with traditional meat production. IntegriCulture has created a patented large-scale cell culture system that allows for the cultivation of a wide range of cells without the need for expensive growth factors, making clean meat more affordable for consumers. Through its innovative technology, IntegriCulture aims to revolutionize the food industry and promote a more sustainable future.

Koala Tech

Venture Round in 2021
Koala Tech Inc., founded in 2019 and based in Fukuoka, Japan, is a high-tech startup focused on developing organic semiconductor laser diodes. The company aims to pioneer practical applications of this innovative technology, which was first realized at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's organic fluorescent semiconductor technology is notable for its ease of processing into thin films, making it less harmful and more efficient. This advancement provides businesses with a low-cost light source that can be seamlessly integrated into OLED and other organic electronic platforms, positioning Koala Tech at the forefront of the organic semiconductor industry.

The Ethical Spirits

Seed Round in 2021
The Ethical Spirits is a craft gin brand that focuses on sustainability by utilizing sake lees from Kuramae, Tokyo, and leftover beer, particularly in response to the challenges posed by the pandemic. The company aims to create a circular economy in the alcoholic beverage industry by producing not only gin but also whiskey and other related products. By offering a monthly subscription service, Ethical Spirits allows consumers to enjoy a variety of flavored drinks while promoting ethical practices in production. The brand aspires to establish itself as a long-lasting presence in the spirits market, aligning quality with environmental responsibility.

Secai Marche

Seed Round in 2021
Secai Marche Inc. operates an online marketplace that connects small-scale farmers with restaurants and consumers, facilitating direct purchases of high-quality food products. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the platform enhances the economic viability of small farms by improving their access to markets. Secai Marche offers services that include sourcing, order processing, payment, and delivery, allowing farmers to sell seasonal and regionally sourced ingredients directly to chefs and businesses. The company's mission is to promote sustainable farming practices and ensure that farmers can achieve a profitable livelihood while providing consumers with fresh and delicious food options.

Libero Thera

Venture Round in 2021
LiberoThera provides drug discovery research and development services. It focuses on making drugs with GPCRs for membrane proteins. LiberoThera was founded in 2018 and is located in Tokyo.

Olive Union

Series B in 2021
Olive Union Inc. is a company that develops innovative hearing aids designed to enhance the hearing experience while addressing common issues related to cost and social stigma. Founded in 2016 and headquartered in Seoul, South Korea, the company utilizes advanced sound algorithms and smart technology to create hearing devices that integrate seamlessly with everyday products. Their devices feature a hearing process engine that allows users to make and receive calls and listen to music, while also offering a smartphone application for personalized hearing tests. This application automatically adjusts audio frequencies based on test results, providing users with optimized sound quality, noise cancellation, and improved hearing range. Olive Union aims to make hearing aids more accessible and socially acceptable, thus contributing to the elimination of hearing impairment.

Gojo & Company

Series D in 2020
Gojo & Company Inc. is a holding company based in Tokyo, Japan, that focuses on enhancing financial inclusion for underserved communities globally. Founded in 2014, the company operates through its subsidiaries, including Microfinance Delta International and Sejaya Micro Credit, to provide microfinance services. Gojo partners with financial service providers across 13 countries in Southeast Asia, South Asia, Central Asia, the Caucasus, and Africa. The company's mission is to ensure that individuals can transcend their circumstances and shape their futures by gaining access to quality and affordable financial services. Through its investments in microfinance institutions, Gojo aims to empower clients in developing regions to improve their lives and achieve financial stability.

Anaut

Seed Round in 2020
Anaut Inc. is a technology company based in Yokohama City, Japan, founded in 2020, that specializes in developing artificial intelligence software for surgical support. The company has created a surgery-support AI system that analyzes complex internal anatomical information in real time, aiding surgeons in visual perception during operations. By leveraging deep learning techniques on a vast array of surgical videos, Anaut aims to enhance the accuracy of its system, broaden the range of surgical applications, and facilitate cross-sectional analysis of surgeries within the chest, abdomen, and pelvic regions. This innovative approach is designed to improve patient safety and manage surgical complications effectively.

Regional Fish

Series A in 2020
Regional Fish Inc., founded in 2019 and based in Kyoto, Japan, specializes in the development of advanced breeding technologies for fish using genome editing and artificial intelligence. The company focuses on creating sustainable land-based aquaculture systems that minimize environmental impact, utilizing clean energy and organic waste nitrogen. By leveraging high-speed breeding techniques, Regional Fish aims to enhance the efficiency of the fisheries industry while promoting natural evolution. Through its innovative approach, the company seeks to transform the aquatic industry and provide consumers with genome-edited food options.

Regional Fish

Seed Round in 2020
Regional Fish Inc., founded in 2019 and based in Kyoto, Japan, specializes in the development of advanced breeding technologies for fish using genome editing and artificial intelligence. The company focuses on creating sustainable land-based aquaculture systems that minimize environmental impact, utilizing clean energy and organic waste nitrogen. By leveraging high-speed breeding techniques, Regional Fish aims to enhance the efficiency of the fisheries industry while promoting natural evolution. Through its innovative approach, the company seeks to transform the aquatic industry and provide consumers with genome-edited food options.

MabGenesis

Series A in 2020
MabGenesis Inc. is a biopharmaceutical company founded in 2019 and based in Yokohama, Japan. The company specializes in developing therapeutic monoclonal antibody drugs for both humans and animals. MabGenesis utilizes advanced antibody library and isolation technologies to discover fully human and canine/feline antibodies. By providing novel antibody therapeutics, the company aims to alleviate symptoms and enhance the quality of life for individuals suffering from various diseases, as well as for their companion animals. MabGenesis also offers licensing opportunities for pharmaceutical companies, thereby contributing to new drug development in the healthcare industry.

IntegriCulture

Series A in 2020
IntegriCulture Inc., founded in 2015 and based in Bunkyo, Japan, specializes in the development of cellular agriculture products, including clean meat and clean foie gras. The company focuses on improving sustainability and food security while addressing public health issues associated with traditional meat production. IntegriCulture has created a patented large-scale cell culture system that allows for the cultivation of a wide range of cells without the need for expensive growth factors, making clean meat more affordable for consumers. Through its innovative technology, IntegriCulture aims to revolutionize the food industry and promote a more sustainable future.

MabGenesis

Seed Round in 2020
MabGenesis Inc. is a biopharmaceutical company founded in 2019 and based in Yokohama, Japan. The company specializes in developing therapeutic monoclonal antibody drugs for both humans and animals. MabGenesis utilizes advanced antibody library and isolation technologies to discover fully human and canine/feline antibodies. By providing novel antibody therapeutics, the company aims to alleviate symptoms and enhance the quality of life for individuals suffering from various diseases, as well as for their companion animals. MabGenesis also offers licensing opportunities for pharmaceutical companies, thereby contributing to new drug development in the healthcare industry.

Grand Green

Series A in 2020
Grand Green, established in 2017 and headquartered in Nagoya, Japan, specializes in the production of new seeds and seedlings through automatic grafting techniques. As a research and development agribio venture, the company focuses on innovative approaches to enhance agricultural practices and improve crop yield. By leveraging advanced technology in seedling production, Grand Green aims to contribute to the agricultural sector's growth and sustainability.

Koala Tech

Venture Round in 2020
Koala Tech Inc., founded in 2019 and based in Fukuoka, Japan, is a high-tech startup focused on developing organic semiconductor laser diodes. The company aims to pioneer practical applications of this innovative technology, which was first realized at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's organic fluorescent semiconductor technology is notable for its ease of processing into thin films, making it less harmful and more efficient. This advancement provides businesses with a low-cost light source that can be seamlessly integrated into OLED and other organic electronic platforms, positioning Koala Tech at the forefront of the organic semiconductor industry.

Secai Marche

Seed Round in 2019
Secai Marche Inc. operates an online marketplace that connects small-scale farmers with restaurants and consumers, facilitating direct purchases of high-quality food products. Founded in 2018 and headquartered in Tokyo, Japan, with an additional office in Kuala Lumpur, Malaysia, the platform enhances the economic viability of small farms by improving their access to markets. Secai Marche offers services that include sourcing, order processing, payment, and delivery, allowing farmers to sell seasonal and regionally sourced ingredients directly to chefs and businesses. The company's mission is to promote sustainable farming practices and ensure that farmers can achieve a profitable livelihood while providing consumers with fresh and delicious food options.

Sonoligo

Venture Round in 2019
Sonoligo Inc. is an online platform based in Kariya, Japan, founded in 2018, that offers access to cultural events and media content through a monthly subscription model. The platform enables users to participate in real events and access online experiences and video content related to music, sports, and art. By providing a flat-rate service, Sonoligo caters to individuals of all age groups, offering a variety of monthly plans to suit diverse interests in cultural activities.

Vitaars

Venture Round in 2019
Vitaars is a Japanese company that specializes in providing remote medical support for Intensive Care Units (ICUs). Headquartered in Kobe, the company addresses the shortage of intensivists in hospitals by offering a tele-intensive care service known as "RELIEVE." This system allows a team of intensivists and certified intensive care nurses to provide 24/7 consultations and support for the treatment of critically ill patients. In addition to direct patient care, Vitaars offers training for doctors and nurses in intensive and emergency care, ensuring that medical personnel are equipped with the latest knowledge and techniques. By facilitating remote consultations and improving the skills of healthcare providers, Vitaars enhances the quality of critical care available to patients across various regions and facilities.

Novenine

Venture Round in 2019
Novenine, Inc., founded in 2018 and headquartered in Osaka, Japan, specializes in oral health care consultation services and the distribution of related products. The company develops and operates innovative dental care solutions, including smart toothbrushes and a teleconsultation platform that connects patients with dental specialists. By focusing on prevention, Novenine enables patients to seek early assistance and take proactive measures against serious dental diseases. Its offerings reflect a commitment to enhancing oral health management through technology and expert guidance.

Koala Tech

Venture Round in 2019
Koala Tech Inc., founded in 2019 and based in Fukuoka, Japan, is a high-tech startup focused on developing organic semiconductor laser diodes. The company aims to pioneer practical applications of this innovative technology, which was first realized at the Center for Organic Photonics and Electronics Research at Kyushu University. Koala Tech's organic fluorescent semiconductor technology is notable for its ease of processing into thin films, making it less harmful and more efficient. This advancement provides businesses with a low-cost light source that can be seamlessly integrated into OLED and other organic electronic platforms, positioning Koala Tech at the forefront of the organic semiconductor industry.

iCare

Venture Round in 2019
iCare Co., Ltd., established in 2011 and headquartered in Tokyo, Japan, specializes in health management solutions. It operates a cloud-based platform that consolidates and securely stores employee health information, including check-up results, stress levels, work hours, and consultation records. iCare's platform is designed to alleviate administrative burdens from businesses, enabling them to better manage employee health and well-being. The company is recognized as the leading health and labor cloud service provider in Japan, catering to both small and medium-sized enterprises and large corporations with global operations.

Photo electron Soul

Venture Round in 2019
Photo Electron Soul Inc. is a Japanese company based in Nagoya, established in July 2015, that specializes in the development and management of photocathode electron beam systems. The company focuses on creating advanced electron beam generating apparatuses that leverage semiconductor photocathode technology. These innovations aim to enhance the capabilities of industrial equipment, including electron microscopes, semiconductor manufacturing and inspection tools, and metal 3D printers. By improving electron beam performance with attributes such as pulse structure, low dispersion, and high current, Photo Electron Soul aims to facilitate fine observation and processing across various sectors, including science, materials, and electronics. The company's mission centers on transforming the fields of observation and processing through cutting-edge technology.

Academist

Series A in 2019
Academist, Inc. is a Tokyo-based company that operates a crowdfunding platform dedicated to acquiring research funds. Founded in April 2013, Academist enables researchers to raise expenses for their projects by connecting them with a broad community of supporters through the internet. The platform allows users to provide funds via one-time or monthly contributions, thereby facilitating direct support for various research themes and initiatives. Through its services, Academist aims to enhance the academic landscape by fostering connections between researchers and potential financial backers.

Metcela

Series A in 2018
Metcela Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for cardiac diseases. Founded in 2016 and based in Kawasaki, Japan, Metcela specializes in fibroblast-based treatments, particularly its lead asset, MTC001. This therapy utilizes VCAM-1-positive Cardiac Fibroblasts, which are derived from the patient's own heart cells. Rather than replacing damaged cells, the therapy enhances the body's natural healing processes to repair heart tissue and restore a favorable microenvironment. Through its research and development efforts, Metcela aims to offer patients an effective and affordable alternative for treating heart failure.

QD Laser

Series F in 2018
QD Laser, Inc. specializes in the development and manufacturing of quantum dot semiconductor lasers and wafers, primarily using GaAs substrates. The company produces a variety of laser technologies, including picosecond short-pulse DFB lasers for precision processing and current injection-type lasers in green, yellow-green, and orange for biological applications. Additionally, QD Laser develops quantum dot laser arrays for silicon optical circuits and broadband gain chips for ophthalmic testing equipment. Their products are utilized in diverse sectors such as telecommunications, manufacturing, medicine, and consumer products, addressing applications in silicon photonics, sensing, and precision machining. Established in 2006 and headquartered in Kawasaki, Japan, QD Laser aims to enhance the performance of semiconductor lasers across various industries.

Vitaars

Secondary Market in 2018
Vitaars is a Japanese company that specializes in providing remote medical support for Intensive Care Units (ICUs). Headquartered in Kobe, the company addresses the shortage of intensivists in hospitals by offering a tele-intensive care service known as "RELIEVE." This system allows a team of intensivists and certified intensive care nurses to provide 24/7 consultations and support for the treatment of critically ill patients. In addition to direct patient care, Vitaars offers training for doctors and nurses in intensive and emergency care, ensuring that medical personnel are equipped with the latest knowledge and techniques. By facilitating remote consultations and improving the skills of healthcare providers, Vitaars enhances the quality of critical care available to patients across various regions and facilities.

Xenoma

Venture Round in 2018
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

IntegriCulture

Seed Round in 2018
IntegriCulture Inc., founded in 2015 and based in Bunkyo, Japan, specializes in the development of cellular agriculture products, including clean meat and clean foie gras. The company focuses on improving sustainability and food security while addressing public health issues associated with traditional meat production. IntegriCulture has created a patented large-scale cell culture system that allows for the cultivation of a wide range of cells without the need for expensive growth factors, making clean meat more affordable for consumers. Through its innovative technology, IntegriCulture aims to revolutionize the food industry and promote a more sustainable future.

Lily MedTech

Series A in 2018
Lily MedTech Inc. is a Tokyo-based company founded in 2016 that specializes in developing and manufacturing medical devices for breast cancer diagnosis. The company focuses on creating innovative ultrasound diagnostic imaging equipment, specifically a ring echo device that utilizes a ring-type ultrasonic transducer to produce 3D images of the entire breast. This approach allows for a non-deforming examination, which minimizes pain and reduces exposure risks for patients during the diagnostic process. Through its advancements in breast ultrasound technology, Lily MedTech aims to enhance the accuracy and comfort of breast cancer detection for both patients and healthcare providers.

Photo electron Soul

Venture Round in 2018
Photo Electron Soul Inc. is a Japanese company based in Nagoya, established in July 2015, that specializes in the development and management of photocathode electron beam systems. The company focuses on creating advanced electron beam generating apparatuses that leverage semiconductor photocathode technology. These innovations aim to enhance the capabilities of industrial equipment, including electron microscopes, semiconductor manufacturing and inspection tools, and metal 3D printers. By improving electron beam performance with attributes such as pulse structure, low dispersion, and high current, Photo Electron Soul aims to facilitate fine observation and processing across various sectors, including science, materials, and electronics. The company's mission centers on transforming the fields of observation and processing through cutting-edge technology.

iCare

Venture Round in 2018
iCare Co., Ltd., established in 2011 and headquartered in Tokyo, Japan, specializes in health management solutions. It operates a cloud-based platform that consolidates and securely stores employee health information, including check-up results, stress levels, work hours, and consultation records. iCare's platform is designed to alleviate administrative burdens from businesses, enabling them to better manage employee health and well-being. The company is recognized as the leading health and labor cloud service provider in Japan, catering to both small and medium-sized enterprises and large corporations with global operations.

Riverfield

Series B in 2017
Riverfield, Inc. is a Tokyo-based company founded in 2014 that specializes in the development of surgical support robotic systems for the healthcare sector. The company's innovative technology focuses on enhancing surgical procedures through advanced air pressure control, which allows for precise and delicate movements. This technology aims to improve the operability and functionality of surgical robots, ultimately enabling medical professionals to perform surgeries with greater accuracy and confidence. Riverfield's commitment to advancing robotic solutions positions it as a significant player in the medical industry.

Xenoma

Series A in 2017
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

Elephantech

Series A in 2017
Elephantech Inc., founded in January 2014 and based in Tokyo, Japan, specializes in the manufacturing of electronic circuits with a focus on sustainability. The company utilizes innovative metal inkjet printing technology to produce flexible printed circuit boards, employing silver nano ink and electroless copper plating. This advanced manufacturing process allows Elephantech to offer clients cost-effective and environmentally friendly solutions. Additionally, the company develops application products using flexible substrates, further enhancing its commitment to sustainable practices in the electric industry.

Myoridge

Seed Round in 2017
Myoridge Co. Ltd. is a biotechnology company based in Kyoto, Japan, that focuses on developing innovative solutions for cell differentiation and drug research. Established in 2016, the company specializes in a suspension culture system that facilitates the scalable differentiation of pluripotent cells into cardiomyocytes without the need for proteins, utilizing a novel small-molecule compound. Myoridge produces iPS cell-derived cardiomyocytes and cardiomyocyte fibers, which are characterized by high maturity and purity, offering excellent drug response rates. Their products also include software for analyzing myocardial motion and fluorescence. By employing a protein-free medium for cell culture, Myoridge achieves low production costs and lot-to-lot uniformity while closely approximating the characteristics of mature human cardiomyocytes. This approach supports advancements in regenerative medicine and drug development technologies.

CureApp

Series A in 2017
CureApp, Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing mobile applications aimed at treating various health conditions, particularly nicotine addiction. The company's flagship product, a nicotine addiction treatment app, was launched in February 2015 in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp is recognized as a prominent player in the digital health sector, focusing on applications that exhibit therapeutic effects against diseases. The company is actively conducting clinical trials to validate the efficacy of its applications. Additionally, CureApp's medical treatment platform allows users to keep daily activity logs, which are analyzed to identify triggers exacerbating their conditions. This technology enables patients to receive personalized guidance in managing lifestyle diseases, addressing health issues that are typically not managed by conventional medications or devices.

OryLab

Venture Round in 2016
Ory Laboratories Inc. is a Tokyo-based company founded in September 2012, specializing in the research, development, manufacturing, and sales of communication technology. The company focuses on creating remote-controlled robots designed to serve as an alter-ego for users. These compact robots are equipped with the ability to communicate and mimic human movements, including the use of hands and neck, all through an internet connection. By addressing the issue of loneliness, OryLab aims to enhance social interaction and connectivity for its users.

Xenoma

Seed Round in 2016
Xenoma, Inc. is a Tokyo-based company specializing in the development of e-skin, a platform for wearable electronic apparel that monitors various physiological functions such as motion, breathing, pressure, and body temperature. As a spin-off from the University of Tokyo's Someya Group Organic Transistor Lab, Xenoma leverages advancements in organic electronics to create ultrathin and ultraflexible devices that seamlessly integrate with the human body. Their innovative clothing line features highly sensitive motion sensors capable of tracking body movement and posture, facilitating the collection of valuable health data. This data can be used to enhance healthcare solutions by combining it with big data analytics, while their products remain comfortable, durable, and machine washable for everyday use.

Riverfield

Venture Round in 2016
Riverfield, Inc. is a Tokyo-based company founded in 2014 that specializes in the development of surgical support robotic systems for the healthcare sector. The company's innovative technology focuses on enhancing surgical procedures through advanced air pressure control, which allows for precise and delicate movements. This technology aims to improve the operability and functionality of surgical robots, ultimately enabling medical professionals to perform surgeries with greater accuracy and confidence. Riverfield's commitment to advancing robotic solutions positions it as a significant player in the medical industry.

Elephantech

Seed Round in 2016
Elephantech Inc., founded in January 2014 and based in Tokyo, Japan, specializes in the manufacturing of electronic circuits with a focus on sustainability. The company utilizes innovative metal inkjet printing technology to produce flexible printed circuit boards, employing silver nano ink and electroless copper plating. This advanced manufacturing process allows Elephantech to offer clients cost-effective and environmentally friendly solutions. Additionally, the company develops application products using flexible substrates, further enhancing its commitment to sustainable practices in the electric industry.

CureApp

Seed Round in 2015
CureApp, Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing mobile applications aimed at treating various health conditions, particularly nicotine addiction. The company's flagship product, a nicotine addiction treatment app, was launched in February 2015 in collaboration with the Division of Pulmonary Medicine at Keio University’s School of Medicine. CureApp is recognized as a prominent player in the digital health sector, focusing on applications that exhibit therapeutic effects against diseases. The company is actively conducting clinical trials to validate the efficacy of its applications. Additionally, CureApp's medical treatment platform allows users to keep daily activity logs, which are analyzed to identify triggers exacerbating their conditions. This technology enables patients to receive personalized guidance in managing lifestyle diseases, addressing health issues that are typically not managed by conventional medications or devices.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.